The Nifty 50 has rallied 16% in 1 year, the Nifty 50 PE is breaking past peaks, and you’re worried that this may be the end of the party and that you may miss further rallies if it isn’t the end. In uncertain markets like these, there’s a great option to both contain losses and generate returns.
Hero MotoCorp dominates the 2-wheeler market. Its firm grip on the entry-level segment serves well to tap the large, growing rural demand and a move towards personal mobility. Recent successful launches have helped the company get back in the premium segment, giving it access to into new markets and drive profitability. PE multiples are similar […]
This company makes a key FMCG input and is also a play on specialty chemicals!
The Mrs Bectors IPO, open now and closing on December 17th, has a price band of Rs 286-288, and seeks to raise up to Rs 540.54 crore. With broad-based revenues and strong regional brands, should you go for this IPO?
Many of you ask us about investing in NFOs. With this article, we hope to give you a playbook on whether and when you should consider investing in NFOs.
Burger King, ‘Home of the Whopper’, needs little introduction. , Burger King India holds the exclusive pan-India right to open and operate outlets under the
A 7% decline in revenue but a 17% jump in profits is not an earnings scenario that you see often. We are talking of the September quarter numbers over a year ago for a universe of 1,122 companies. But then, abnormal times throw up abnormal results. How did India Inc achieve these profitability numbers and are they here to stay?
When you have a holding period that is less than 3 years, your options are limited. Because this short period gives very little room for risk, pure equity is out of the question. But in debt funds, though returns may be reasonable, taxation for a less than 3-year period cuts into return. Equity savings funds fit this gap.
Which are the best SIP funds? I want to invest lumpsum, which fund should I go for? Are your Prime Portfolios for SIP or lumpsum investing? These are some of the questions we see from you and in discussion forums online. Here’s the answer.
When you decide to switch funds because your scheme is doing poorly, the dominant question in your mind is this: should I do a lumpsum switch or use SIP? What if you reinvest your money at one go, and there’s a correction? Since it’s a new investment in a new fund, shouldn’t you stagger your investments to avoid poor market timing? If you stagger the reinvestment, wouldn’t you be getting an additional rupee cost averaging benefit?
The second main strategy that debt funds follow is duration. In this article, we’ll cover what a duration strategy in debt funds is, which categories follow duration, and whether you should invest in such funds.
When you have too much of your portfolio invested in fund(s) of a single AMC, you’re concentrated towards an AMC. So you might think. But it’s not that cut-and-dried. AMC concentration risk comes in only when the funds are of a similar type or when you have too much of your portfolio in a single fund.
The purpose of these disclosures is to provide essential information about the Research Services in a manner to assist and enable the prospective client/client in making an informed decision for engaging in Research services before onboarding. History, Present business and Background: PrimeInvestor Financial Research Private Limited is registered with SEBI as Research Analyst with registration no. INH200008653. The Research Analyst got its registration on August 19, 2021 and is engaged in offering research and recommendation services. Terms and conditions of Research Services: The Research Services will be limited to providing independent research recommendation and shall not be involved in any advisory or portfolio allocation services. The Research Analyst never guarantees the returns on the recommendation provided. Investor shall take note that Investment/trading in stocks/Index or other securities is always subject to market risk. Past performance is never a guarantee of same future results. The Research Analyst shall not be responsible for any loss to the Investors. Disciplinary history: There are no pending material litigations or legal proceedings against the Research Analyst. As on date, no penalties / directions have been issued by SEBI under the SEBI Act or Regulations made there under against the Research Analyst relating to Research Analyst services. Details of its associates: No associates. Disclosures with respect to Research and Recommendations Services: The Research Analyst or its directors or any of its officer/employee does not trade in securities which are subject matter of recommendation. There are no actual or potential conflicts of interest arising from any connection to or association with any issuer of products/ securities, including any material information or facts that might compromise its objectivity or independence in the carrying on of Research Analyst services. Such conflict of interest shall be disclosed to the client as and when they arise. Research Analyst or its directors or its employee or its associates have not received any compensation from the company which is subject matter of recommendation. Research Analyst or its directors or its employee or its associates have not managed or co-managed the public offering of any company. Research Analyst or its directors or its employee or its associates have not received any compensation for investment banking or merchant banking of brokerage services from the subject company. Research Analyst or its directors or its employee or its associates have not received any compensation for products or services other than above from the subject company. Research Analyst or its directors or its employee or its associates have not received any compensation or other benefits from the Subject Company or 3rd party in connection with the research report/ recommendation. The subject company was not a client of Research Analyst or its directors or its employee or its associates during twelve months preceding the date of recommendation services provided. Research Analysts or its directors or its employee or its associates has not served as an officer, director or employee of the subject company. Research Analysts has not been engaged in market making activity of the subject company.
Full disclosures and disclaimers
Compliance Officer Details: Name: Srikanth Meenakshi; Email: contact@primeinvestor.
Grievance Officer Details: Name: Srikanth Meenakshi; Email: contact@primeinvestor.
